Aurobindo Pharma Limited has informed the Exchange about Schedule of meet
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aurobindo Pharma has disclosed that company officials will participate in an investor meeting with Investec's US Pharma and Healthcare Bus Tour 7.0 on June 4, 2026. The meeting is scheduled from 13:00 to 15:00 EDT in New Jersey, USA. This is a group meeting format. The company has clarified that no unpublished price sensitive information (UPSI) will be discussed during the interaction. This is a routine regulatory disclosure to keep exchanges informed about investor engagement activities.
This is a standard investor relations activity disclosure with no material impact expected on the stock. The explicit mention that no UPSI will be shared provides clarity and prevents any regulatory concerns.